Marit J. van Gils

University of Amsterdam - Department of Medical Microbiology and Infection Prevention

Amsterdam

Netherlands

SCHOLARLY PAPERS

4

DOWNLOADS

256

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (4)

1.

The Effect of SARS-CoV-2 Vaccination on Post-Acute COVID-19 Syndrome (PACS): A Prospective Cohort Study

Number of pages: 32 Posted: 31 Jan 2022
Public Health Service of Amsterdam - Department of Infectious Diseases, University of Amsterdam - Department of Medical Microbiology & Infection Prevention, Public Health Service of Amsterdam - Department of Infectious Diseases, Amsterdam University Medical Centre, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Amsterdam Public Health Research Institute, Amsterdam University Medical Centres, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Amsterdam Institute for Infection and Immunity, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Department of Medical Microbiology, Public Health Service of Amsterdam - Department of Infectious Diseases, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Amsterdam Public Health Research Institute, Public Health Service of Amsterdam - Department of Infectious Diseases and affiliation not provided to SSRN
Downloads 171 (277,818)
Citation 1

Abstract:

Loading...

COVID-19, vaccination, long COVID, post-acute COVID-19 syndrome, symptoms

2.

Fourth mRNA COVID-19 Vaccination in Immunocompromised Patients with Hematologic Malignancies

Number of pages: 23 Posted: 06 Mar 2023
University of Amsterdam, Academic Medical Center, Department of Hematology, University of Amsterdam, Academic Medical Center, Department of Hematology, University of Amsterdam - Department of Clinical Epidemiology, Biostatistics and Bioinformation, Erasmus University Rotterdam (EUR) - Department of Hematology, University of Groningen - Department of Hematology and Oncology, National Institute for Public Health and the Environment (RIVM) - Department for Immunology of Infectious Diseases and Vaccination (IIV), National Institute for Public Health and the Environment (RIVM) - Department of Immune Surveillance, University of Amsterdam, Academic Medical Center, Department of Hematology, University of Amsterdam - Amsterdam Institute for Infection and Immunity, Vrije Universiteit Amsterdam - Department of Hematology, University of Amsterdam - Amsterdam Institute for Infection and Immunity, University of Amsterdam - Amsterdam Institute for Infection and Immunity, National Institute of Public Health and the Environment, University of Amsterdam - Central Diagnostic Laboratory, University of Amsterdam - Amsterdam Institute for Infection and Immunity, Free University, Amsterdam - Medical Immunology Laboratory, University of Amsterdam - Amsterdam Institute for Infection and Immunity, Netherlands Comprehensive Cancer Organisation, National Institute for Public Health and the Environment (RIVM) - Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM) - Department for Immunology of Infectious Diseases and Vaccination (IIV), Leiden University, Medical Center (LUMC), Department of Hematology, Vrije Universiteit Amsterdam - Department of Hematology, University of Groningen - Department of Hematology and Oncology, Erasmus University Rotterdam (EUR) - Department of Hematology, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Department of Infectious Diseases, University of Amsterdam, Academic Medical Center, Department of Hematology, University of Amsterdam, Academic Medical Center, Department of Hematology, Vrije Universiteit Amsterdam - Department of Hematology and Independent
Downloads 60 (561,805)

Abstract:

Loading...

Humoral immunogenicity, Antibody response, SARS-CoV-2, COVID-19 vaccination, Booster vaccination, Hematologic malignancies, Immunocompromised

3.

Identification of New Drugs to Counteract Anti-Spike IgG-Induced Hyperinflammation in Severe COVID-19

Number of pages: 30 Posted: 20 Jan 2023
University of Amsterdam - Center for Experimental and Molecular Medicine, University of Amsterdam - Center for Experimental and Molecular Medicine, University of Reading - School of Biological Sciences, University of Amsterdam - Department of Pulmonary Medicine, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Amsterdam Cardiovascular Sciences, University of Amsterdam - Center for Experimental and Molecular Medicine, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Center for Experimental and Molecular Medicine, University of Amsterdam - Department of Intensive Care, Independent, Sanquin Research - Department of Immunopathology, University of Amsterdam - Department of Pulmonary Medicine, University of Amsterdam - Department of Pulmonary Medicine, University of Reading - School of Biological Sciences, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Amsterdam Cardiovascular Sciences and University of Amsterdam - Center for Experimental and Molecular Medicine
Downloads 13 (873,797)

Abstract:

Loading...

COVID-19 treatment, SYK, macrophage, FcR, entospletinib, Inflammation, IL-6, thrombosis, endothelial dysfunction, platelet

4.

Recent Infection With HCoV-OC43 Is Associated With Protection Against Sars-Cov-2 Infection

Number of pages: 32 Posted: 23 Mar 2022
VU University Amsterdam - Department of Internal Medicine, VU University Amsterdam - Department of Internal Medicine, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, VU University Amsterdam - Department of Internal Medicine, University of Amsterdam - Center for Experimental and Molecular Medicine, University of Amsterdam - Amsterdam Institute for Infection and Immunity, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Department of Internal Medicine, VU University Amsterdam - Department of Internal Medicine, VU University Amsterdam - Department of Internal Medicine, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Department of Medical Microbiology and Infection Prevention and VU University Amsterdam - Department of Internal Medicine
Downloads 12 (882,931)

Abstract:

Loading...

Coronavirus, antibodies, OC43, NL63, HKU1, 229E, SARS-CoV-2, COVID-19